Coronary and peripheral arterial stenting with drug-eluting platforms — the metallic scaffolds delivering antiproliferative agents (sirolimus, paclitaxel, everolimus, zotarolimus) to prevent restenosis representing the dominant intervention in arterial revascularization — creates the most commercially mature yet innovation-driven market segment, with the Arterial Stents Market...